Tel./Phone:  +49 201 43 70 97 0

PakuMed Port GroßKatGW 5964 PakuMed Port Groß GW 5303 PakuMed Katheter GW 5785 PakuMed Umverpackung GW 5932 PakuMedSML01

PakuMed Port GroßKatGW 5964 PakuMed Port Groß GW 5303 PakuMed Katheter GW 5785 PakuMed Umverpackung GW 5932 PakuMedSML01

Product description

TITAN-PORT Systems are totally implantable port catheter systems consisting of an injection chamber (port), a screw closure machanism, a self-sealing silicone membrane and a catheter. Each system includes a special access needle, a dilatator, catheter introducer, these instructions for use and a patient ID-card. Some sets contain introduction instruments and tunnelizers.

The portal chamber is made of hypoallergenic biocompatible titanium. This material is non-magnetic. The base plate has
holes for securing the system to the fascia with sutures.The portal chamber and the catheter can be disconnected.

The silicone membrane can be punctured frequently (up to 3000 times) with a suitable special needle, e.g. the enclosed SFN non-coring access needle. The membrane is highly resistant to pressure and holds the inserted needle reliably in place.

The catheter (various models, sizes and materials - depending on indication) can be shortened proximally to the individual length required. It bears calibration markings at 5 cm length intervals and is conically tapered at the tip. It has an additional opening at the side (especially to facilitate blood sampling). The arterial catheter has two additional distal fixation rings.

Introduction instruments include a puncture needle, a guide wire, and a dilatator which facilitate introduction of catheters into the blod vessels via Seldinger's technique. The tunnelizer aids in passing the catheter through the subcutaneous tissues.

Only special non-coring portal access needles (e.g. SFN portneedles) should be used to puncture the port membrane. The needles exhibit a unique bevel and angle at the tip. This prevents punch defects of the membrane when the needle is inserted. Different lengths and diameters are available. 22 G or 20 G is recommended for standard use. Each system contains a suitable needle.

The patient ID-card is filled out by the doctor who performed the implantation and is given to the patients who should always carry this document with them. 

The instructions for use should also be available to nurses and doctors responsible for follow-up care.

MR conditional

TITAN port catheter systems are MR-conditioned-safe. On request, we will be happy to provide you with further information.


Technical data

CompletE sets
Art. No. Port Catheter PZN
  Material Base Height Septum Ø Weight Reservoir Material OD ID Lenght French  
111244 P-N paediatric (venous) Titanium 21 mm 9,8 mm 8 mm <10g 0,4 ml Polyurethane 0,95 mm 0,46 mm 700 mm 3,0 01673103
111245 P-SET *paediatric (venous) Titanium 21 mm 9,8 mm 8 mm <10g 0,4 ml Polyurethane 1,7 mm 0,9 mm 700 mm 5,15 00199289
111251 A (arterial) Titanium 21 mm 9,8 mm 8 mm <10g 0,4 ml Polyurethane** 1,7 mm 0,9 mm 700 mm 5,15 01673793

* SET including introducer set and tunnelizer
** with fixation rings

Instruction for use

The TITAN-PORT Systems ensure repeated access to the vascular system for example for the following indications:

  • infusion therapy and long-term parenteral nutrition
  • systemic chemotherapy
  • administration of medications
  • regional chemotherapy 
  • pain therapy
  • blood sampling, poor vascular situation
  • long-term venous access

In addition, the systems may be used for the following indications:

  • TITAN-PORT A (arterial): for direct perfusion of organs, for inoperable hepatic metastases via the gastroduodenal artery, via the coeliac trunk for pancreatic and via the aorta and internal iliac arteries for pelvic neoplasms
  • TITAN-PORT APH: for apheresis
  • TITAN-PORT AS/PT: for ascites- and peritoneal therapy
  • TITAN-PORT D: for dialysis venous ↔ venous
  • TITAN-PORT DR: for drainage
  • TITAN-PORT P: for pediatrics
  • TITAN-PORT F: for fetal treatment
  • TITAN-PORT UA: sideport

The TITAN-PORT systems should not be used in:

  • extremely rare but possible hypersensitivity to silicone, polyurethane or titanium
  • suspected bacteremia or sepsis
  • disseminated intravascular coagulation (DIC)

The following complications or adverse reactions can occur:

  • technical intraoperative complications
  • tissue incompatibility
  • local reactions (inflammation, edema, hematoma)
  • infection
  • disconnection or dislocation
  • thrombosis / thromboembolism
  • breakage of the catheter between the clavicle and first rib
  • breakage of catheter or damage to catheter
  • torsion of chamber or catheter
  • perforation of catheter
  • drug extravasation due to improper handling of the system
  • damage to neighboring tissue by the pharmaceutical agents (in the event of leakage of portal components)

Caution: During implantation sterile handling is absolutely mandatory!

  • various techniques are available for implantation of port and catheter, including the Seldinger technique
  • the choice depends on the surgeon's preference
  • the implantation of TITAN-PORT Standard is usually possible under local anesthesia,
  • recommended sites for venous catheter placement include the cephalic vein, subclavian vein, or internal and external jugular veins
  • preferably use a 10 ml syringe and only special non-coring needles for puncturing the septum. The needles are intended for single use only
  • do not use syringes < 10 ml (danger of overload pressure)
  • the neelde should be inserted into the silicone membrane carefully and always vertically to avoid bending the tip
  • if the situation is unclear or thrombotic obstruction is suspected a radiagraphic or doppler sonographic control is necessary

To achieve greater flow rates the port membrane may be accessed simultaneously with up to three needles.

  • a venous implantation should be flushed with 20 ml 0,9% saline solution once every 3 months if the system is not used
  • an arterial implantation requires flushing once every 2 weeks
  • for sampling venous blood 3 ml of blood schould initially be aspirated and discarded. A minimum 20 G needle should be used and the required amount of blood aspirated slowly (to avoid falsification of the results)
    * note: 18 G or 19 G needle is recommended for blood transfusion! Afterwards the system must be flushed immediately with at least 20-50 ml 0,9% saline solution. During the flushing procedure the needle may be rotated in different directions to ensure unifrom rinsing of the chamber interior
  • to avoid interactions between various drugs (cytostatic agents in particular) the system must be flushed with at least 10 ml 0,9% saline when repeated infusions are required
  • the system must be flushed after each use. The needle is removed with gentle force
  • when using needles with tube the lock schould be activated to avoid getting blood into the system
  • catheter obstruction due to thrombus formation can usually be cleared by injecting Streptokinase / Urokinase (e.g. 5000 IE/ml physiologic saline with 10 ml syringe, small amounts should be injected at intervals, allowed time to take effect and the patency checked)

(The above-mentioned concentrations are recommendations and must always be adapted to patient's coagulation status as monitored by a physician. The product description of all pharmaceuticals used should always be consulted.)

  • The complication rate of thrombus formation in the catheter can be reduced in patients at risk by low-dose heparinization
  • in arterial portal systems, by the administration of a platelet aggregation inhibitor (e.g. acetylsalicylic acid).

CAUTION: High-pressure injections not unless patency of the system is confirmed by the physician (aspiration, manual injection). In case of any doubt injection should be avoided!

Causes of abnormally high resistance to access needle may include

  • incorrect placement of the access needle in the portal chamber
  • bending and kinking of the catheter
  • fibrin deposition or thrombotic occlusion of catheter or port.

CAUTION: When blood aspiration is not successful, the port should be flushed and the patient's position changed.

Blood deposits in the system generally indicate one of the following causes:

  • leakage of the system
  • defective septum
  • faulty handling



  • the port can be removed under local anesthesia at the end of treatment (explantation is possible under local anesthesia)
  • irreversible obstruction of the portal system
  • breakage of catheter or damage to catheter
  • membrane leakage
  • poor patient compliance
  • massive thrombosis of the major vessels (subclavian vein, v.cava)
  • uncontrollable infection (port removal only under general anesthesia


  • the port should be secured to surrounding subcutaneous tissue by sutures or placed in the smallest of portal pockets in order to prevent port migration
  • the catheter must be secured to the vein with a firm, but not constricting suture
  • the proper connection of the catheter to the port must be confirmed


Meticulous hygiene and sterile handling technique are mandatory for the safe usage of TITAN-PORT Systems. This includes:

  • implantation in sterile OP setting
  • proper disinfection of hands and skin
  • sterile gloves when initiating treatment
  • use of sterile products


Regular treatment sessions and associated care of the port system are coincidental with monitoring of the port system.
Port systems should not be used be physicians / health care personnel not familiar with all aspects of the product and its potential complications. Complications can occure at any time during and after implantation.


Before each access the correct position of the portal chamber must be checked by palpation.
Any signs of infection must be excluded. Without complications the TITAN-PORT Systems can be used one day after implantation.

Palpation Port

PakuMed medical products © 2022